Pabau GO app

The new Pabau GO is heredownload on the App Store

Download on the App Store
Book a demo Book a demo
Mental Health & Therapy

7 Stages of dementia chart

Key Takeaways

Key Takeaways

The 7 stages of dementia chart categorizes cognitive decline using the Global Deterioration Scale (GDS), developed by Dr. Barry Reisberg.

Stages 1-3 represent early decline (no cognitive change to mild cognitive decline); stages 4-7 represent moderate to severe decline requiring escalating care.

The FAST scale complements GDS by assessing functional decline, particularly useful for Alzheimer’s disease and hospice eligibility determination.

Clinicians use the 7 stages of dementia chart to create individualized care plans, track progression, and communicate expected timelines with patients and families.

Download Your Free 7 Stages of Dementia Chart

A clinical assessment tool providing a structured framework for understanding and tracking cognitive decline progression across the seven stages, from normal cognitive function through severe cognitive decline. Enables more effective care planning and patient communication for healthcare professionals.

Download template

The 7 stages of dementia chart, based on Dr. Barry Reisberg’s Global Deterioration Scale (GDS), provides a systematic framework to track changes and communicate expected trajectories with patients and families.

Combined with the FAST scale (Functional Assessment Staging Tool), this reference tool helps mental health practice management software users and clinicians across settings establish accurate diagnoses, plan interventions, and prepare patients for what lies ahead.

What is a 7 stages of dementia chart?

The 7 stages of dementia chart is a clinical classification system that categorizes the progression of dementia from normal aging through severe cognitive decline. The Global Deterioration Scale (GDS), created by Dr. Barry Reisberg in 1982, divides this journey into seven distinct stages, each marked by measurable changes in cognition, function, and behavior.

This tool serves a clinical purpose: it standardizes how practitioners assess and communicate disease severity. Rather than relying on subjective impressions, clinicians use specific cognitive and functional criteria to place a patient within a stage. The FAST scale complements GDS by focusing on observable functional changes in activities of daily living (ADLs) – what patients can and cannot do in everyday life.

The Centers for Medicare & Medicaid Services (CMS) uses the FAST scale, specifically Stage 7C criteria, to determine hospice eligibility for dementia patients. This makes accurate staging essential not only for care planning but also for determining access to end-of-life services.

How to use this chart

Using the 7 stages of dementia chart involves five core operational steps that clinicians integrate into their assessment workflow.

  1. Conduct baseline cognitive assessment: Administer a brief screening tool (Mini-Mental State Examination, Montreal Cognitive Assessment, or Clinical Dementia Rating Scale). Document scores in the patient’s record to establish baseline function and track decline over future visits.
  2. Evaluate functional independence in ADLs: Assess the patient’s ability to manage self-care (bathing, dressing, toileting), meal preparation, medication management, and financial tasks. Functional decline often precedes cognitive decline and is a key staging indicator.
  3. Map behavioral and mood changes: Identify emerging symptoms such as sundowning, wandering, aggression, anxiety, or depression. Document the frequency and triggers. These behavioral flags signal progression and inform care strategies.
  4. Place the patient in a stage: Cross-reference cognitive scores, functional losses, and behavioral patterns against the GDS/FAST criteria. A patient with mild memory loss and preserved ADL function is Stage 2-3; a patient unable to recognize family members is Stage 6.
  5. Create a stage-specific care plan: Use digital assessment forms and organized client records to document the staging assessment, anticipated progression timeline, and recommended interventions (cognitive engagement for Stage 3, assistance with ADLs for Stage 5, palliative focus for Stage 7).

Within each stage, clinicians also use structured clinical notes to record specific observations (e.g., “Patient at Stage 4: Moderate cognitive decline. Forgetful of recent events. ADLs intact but requires reminders. Wife reports frustration at lost keys twice this week.”). This level of detail supports continuity of care and justifies treatment intensity.

Who is this chart helpful for?

The 7 stages of dementia chart is essential for clinicians working across multiple disciplines and settings.

  • Geriatric medicine practitioners conducting routine cognitive screening and tracking decline in older adult populations.
  • Psychiatrists and neurologists diagnosing dementia types (Alzheimer’s, vascular, Lewy body) and staging disease severity for treatment selection.
  • Primary care physicians managing dementia in the community setting and coordinating referrals to specialists or hospice.
  • Therapists and counselors using psychology practice management software to document cognitive and emotional changes alongside treatment progress.
  • Nursing staff in long-term care facilities assessing baseline function and reporting changes to the care team.
  • Care coordinators and social workers identifying appropriate community resources, adult day programs, or assisted living based on stage-specific functional needs.

Organizations providing patient care planning workflows benefit from embedding the 7 stages framework into their assessment protocols, ensuring consistent staging across clinicians.

Benefits of using a chart to track the 7 stages of dementia

A standardized 7 stages of dementia chart delivers three core clinical benefits.

Accuracy and consistency: Staging relies on objective criteria (cognitive test scores, functional loss, documented behaviors) rather than clinician impression. This reduces diagnostic drift and ensures all team members are tracking the same stage. When AI-assisted documentation systems capture these observations, accuracy improves further by organizing scattered notes into stage-specific criteria automatically.

Creating treatment notes with Echo AI
Creating treatment notes with Echo AI

Regulatory compliance and reimbursement: CMS uses FAST scale staging to determine hospice coverage. Accurate documentation of dementia stage determines whether a patient qualifies for palliative services and what level of regulatory compliance tracking is required. Without proper staging records, claims are denied and care is delayed.

HIPAA compliance in Pabau
HIPAA compliance in Pabau

Family communication and realistic expectations: Staging allows clinicians to answer the question families ask most: “What comes next?” A Stage 3 patient’s family learns that early-stage decline typically lasts 2-7 years and that the focus is cognitive engagement and safety planning. A Stage 6 family understands that end-of-life preparations are now appropriate. This honesty reduces caregiver shock and enables proactive decision-making.

Understanding each stage: The global deterioration scale

The GDS organizes dementia into seven stages. Stages 1-3 represent early cognitive decline; stages 4-5 represent middle decline; stages 6-7 represent late or end-stage decline. Duration varies widely based on age at onset, dementia type, overall health, and concurrent conditions.

  • Stage 1 (Normal cognitive function): No memory loss or functional change. Used as a baseline to contrast future decline.
  • Stage 2 (Very mild cognitive decline): Occasional memory lapses (lost keys, forgotten names) that do not impact function. Complaints are subjective; no deficit is evident on clinical testing or to family and coworkers.
  • Stage 3 (Mild cognitive decline): Noticeable memory loss, mild difficulty with complex tasks, occasional disorientation to date/time. Work performance may slip; loved ones begin to notice. Lasts 2-7 years typically.
  • Stage 4 (Moderate cognitive decline): Definite memory loss, confusion about current events, difficulty with finances or complex ADLs. Personality changes emerge. Patient may withdraw socially. Lasts 2-10 years.
  • Stage 5 (Moderately severe cognitive decline): Significant memory loss, confusion about personal history, disorientation to place/time, behavioral changes. Requires assistance with ADLs (dressing, hygiene, meals). Lasts 1-3 years.
  • Stage 6 (Severe cognitive decline): Severe memory loss, loss of recognition of family, personality changes, behavioral symptoms (wandering, sundowning, aggression), incontinence, inability to perform ADLs. Lasts 2-10 years.
  • Stage 7 (Very severe cognitive decline): Loss of speech, loss of motor function, loss of ability to eat or drink safely. Requires 24-hour care. Lasts 1-3 years until death.

Use safe documentation practices when recording stage-specific behavioral symptoms. Avoid stigmatizing language; focus on observable function and safety considerations.

Pro Tip

Flag stage transitions in patient records immediately. When a patient moves from Stage 3 to Stage 4, document the date, triggering observations (new functional loss, new behavior change), and any plan adjustments. These transition notes become the evidence for care escalation and family conversations.

The FAST scale: Functional Assessment Staging Tool

The FAST scale (Functional Assessment Staging Tool) is often used alongside GDS because it emphasizes functional loss rather than cognitive scores. FAST is particularly useful in Alzheimer’s disease and is the tool CMS uses for hospice eligibility.

FAST stages 1-3 correspond to GDS stages 1-3 (normal to mild decline). FAST stage 4 begins at GDS stage 4. However, FAST includes substages (6a-6e and 7a-7f) that divide the later stages into smaller functional checkpoints. For example, FAST stage 6e indicates the patient has developed fecal incontinence; FAST stage 7c indicates the patient has lost the ability to ambulate (walk) independently.

Clinicians document FAST stage during assessment and note any behavioral or functional changes at subsequent visits. When a patient reaches FAST stage 7c (typically indicating life expectancy under 6 months), the hospice referral conversation becomes timely. Use patient engagement throughout care strategies to keep families informed of stage transitions and care plan adjustments.

Clinical documentation tips for dementia staging

Effective dementia documentation supports both clinical continuity and compliance.

  • Use baseline scores: Record initial cognitive test results (MMSE, MoCA, CDR scores) in the patient’s chart. Use the same test at each follow-up so trends are visible and comparable.
  • Document functional observations: Note what the patient can and cannot do: “Able to dress self with reminders. Unable to manage medication independently. Wife reports patient became lost walking to mailbox last week.”
  • Track behavioral symptoms: Record frequency and triggers: “Sundowning occurs most days after 5 PM. Increases confusion and agitation. Managed with evening routine modification.”
  • Note GDS/FAST stage and rationale: Write: “Stage 5 dementia (moderately severe). Rationale: MMSE 16/30, unable to prepare meals, needs help with bathing, wife reports new incontinence, disorientation to date.” This documents the reasoning for staging.
  • Plan care escalation: For each stage, document the next anticipated functional loss and the care adjustments needed. “Anticipate Stage 6 transition within 12-18 months. Plan: discuss long-term care options; initiate caregiver respite program; evaluate behavioral symptoms for medication need.”

Teams using therapy practice workflows that integrate dementia care benefit from embedding these staging checkpoints into assessment forms, ensuring no step is missed.

Dementia staging in your clinical practice

Implementing the 7 stages of dementia chart starts with training your team on GDS and FAST criteria, establishing when to administer cognitive tests, and defining your documentation expectations. Most practices integrate staging into the initial comprehensive geriatric assessment and then re-assess annually or when functional changes appear.

The downloadable 7 stages of dementia chart above provides a visual reference your team can post in exam rooms or include in patient education materials. Use it during family meetings to explain expected progression and justify care intensity.

Questions about when to stage, how to document behavioral changes, or how to explain stages to families often arise during practice implementation. The resources below provide additional clinical depth and workflow guidance.

Book a demo to learn how Pabau’s clinical documentation and care planning tools support dementia staging and team workflows.

Frequently Asked Questions

What is the 7 stages of dementia chart?

The 7 stages of dementia chart is a clinical staging tool based on Dr. Barry Reisberg’s Global Deterioration Scale. It categorizes dementia progression from no cognitive impairment (Stage 1) through very severe cognitive decline (Stage 7), helping clinicians track disease severity, plan interventions, and communicate prognosis to patients and families.

How long do the 7 stages of dementia last?

Stage duration varies widely. Early stages (2-3) typically last 2-7 years. Middle stages (4-5) last 2-10 years. Late stages (6-7) last 1-10 years. Total dementia duration from diagnosis to death averages 8-10 years, but ranges from 3 to 20+ years depending on age at onset, dementia type, and overall health. These are estimates; individual trajectories differ significantly.

What is the difference between the GDS and FAST scale?

The Global Deterioration Scale (GDS) focuses on cognitive decline and severity. The FAST scale (Functional Assessment Staging Tool) focuses on functional loss in activities of daily living. Both describe the same disease progression but emphasize different aspects. FAST includes substages and is the tool used by CMS for hospice eligibility determination.

When should I use the 7 stages of dementia chart in clinical practice?

Use the chart during the initial comprehensive geriatric assessment to establish baseline stage, then re-assess annually or when patients report functional changes. Document stage in the medical record, use it to explain prognosis during family meetings, and reference it when planning care escalation or making referrals to specialists or hospice.

What behaviors appear at each stage of dementia?

Early stages show occasional memory loss and mild personality changes. Middle stages bring noticeable memory loss, confusion, social withdrawal, and early behavioral changes. Late stages feature significant behavioral symptoms: sundowning, wandering, aggression, incontinence, and eventual loss of speech and motor function. Behavioral symptoms vary by dementia type and individual; no two patients progress identically.

What is FAST stage 7c and why does it matter?

FAST stage 7c marks the loss of independent ambulation – the patient can no longer walk without assistance. It is a key hospice-eligibility threshold: CMS uses FAST stage 7c (or beyond), together with qualifying comorbidities, to determine hospice eligibility, where life expectancy is typically under 6 months. (The final FAST substage is 7f, loss of the ability to hold the head up.) Documentation of FAST stage 7c justifies palliative care focus and initiates end-of-life care conversations with families.

×